Nevertheless, CDKN2A PVs are sometimes found as a secondary finding in breast cancer panel testing, with its role in this type of cancer still poorly elucidated [20, 22], and some of the cancer cases in the paternal line of this patient could be related to a CDKN2A spectrum, with molecular confirmation needed. Here, CDKN2A is linked to breast carcinoma.